IBEX vs RARE · P/E 13, rev $558.3M vs rev $350.0M
IBEX Ltd (IBEX) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
IBEX Ltd (IBEX) is a information technology services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported IBEX revenue for 2025-06-30 was $558.3M. Net income was $36.9M. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
IBEX currently screens at market cap $388.5M and trailing P/E 12.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the IBEX and RARE stock pages for the full models.
Not investment advice.